PROSTATE CANCER SCREENING WITHIN A PROSTATE SPECIFIC ANTIGEN RANGE OF 3 TO 3.9 NG./ML.: A COMPARISON OF DIGITAL RECTAL EXAMINATION AND FREE PROSTATE SPECIFIC ANTIGEN AS SUPPLEMENTAL SCREENING TESTS
✍ Scribed by MÄKINEN, T.; TAMMELA, T.L.J.; HAKAMA, M.; STENMAN, U.-H.; RANNIKKO, S.; ARO, J.; JUUSELA, H.; MÄÄTTÄNEN, L.; AUVINEN, A.
- Book ID
- 123592524
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2001
- Tongue
- English
- Weight
- 51 KB
- Volume
- 166
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. The 11,811 first visits and 46,751 annual follow-up visits performed since 1988 were analyzed in order to assess the efficacy of serum prostatic specific antigen (PSA) and digital rectal examination (DRE) for diagnosis of prostate cancer. METHODS. At first visit, screening included
The purpose of this study was to examine the diagnostic efficiency of prostate-specific antigen (PSA) and digital rectal examination (DRE) testing when using either 4.0 ng/ml or an age-specific reference range (ASRR) as an abnormal cutoff PSA value. METHODS. Between 1992Between -1995, 116, 116,073 m